Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
Clinical trial NCT04164199 · COMPLETED
Trial details
- NCT number
- NCT04164199
- Sponsor
- BeOne Medicines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-19
- Primary completion
- 2026-05-23
- Enrollment
- 404
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.